Profile
| Metric | Value |
|---|---|
| Full Name | Carisma Therapeutics, Inc. |
| Ticker | NASDAQ: CARM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | carismatx.com |
| Employees | 46 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.04 | ||
| Price, 1D Change | 0.00% | |
| $2M | ||
| - | ||
| 0.21 | ||
| 1.15 | ||
| $20M | ||
| Revenue, 1Y Change | +31.59% | |
| -$1.46 | ||
| EPS, 1Y Change | +43.71% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.36 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | SESN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.46 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $19.63M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.04 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.52 | -$2.59 | -2.84% | |
| -$1.20 | -$1.46 | -21.57% | |
| - | N/A | - | |
| -$0.52 | N/A | +64.35% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $13.54M | $14.92M | +10.18% | |
| $21.41M | $19.63M | -8.29% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -92.20% | ||
| -99.66% | ||
| -92.18% | ||
| -98.61% | ||
| +31.59% | ||
| -26.04% | ||
| +43.71% | ||
| -3,864.13% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.04 | ||
| $0.20 | ||
| SMA 200 vs Price | +421.03% | |
| $0.05 | ||
| SMA 50 vs Price | +17.44% | |
| 1.15 | ||
| $0.01 | ||
| 41.67 | ||
| 84.11% | ||
| 438.09% |
Dividends
| Metric | Date | Value |
|---|---|---|
| $0.36 | ||
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $19.63M | ||
| -$1.46 | ||
| $16.28M | ||
| 82.92% | ||
| -$62.18M | ||
| -316.72% | ||
| -$60.48M | ||
| -308.05% | ||
| -$58.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.09 | ||
| 1.48 | ||
| 1.48 | ||
| - | ||
| 4 | ||
| -19.82 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 0.21 | ||
| 0.03 | ||
| -1.88 | ||
| -0.03 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$27.91M | ||
| $17.91M | ||
| $30.46M | ||
| $23.83M | ||
| $58.37M | ||
| $16.06M | ||
| $2.48M | ||
| $1.74M | ||
| $2.08M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $80.11M | ||
| $78.46M | ||
| $3.35M | ||
| $0.00 | ||
| $3.35M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$59.92M | ||
| -$123.00K | ||
| $344.00K | ||
| $123.00K | ||
| -$60.04M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| Baird | → | |
| Evercore ISI Group | → | |
| BTIG | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CARM
FAQ
What is the ticker symbol for Carisma Therapeutics, Inc.?
The ticker symbol for Carisma Therapeutics, Inc. is NASDAQ:CARM
Does Carisma Therapeutics, Inc. pay dividends?
No, Carisma Therapeutics, Inc. does not pay dividends
What sector is Carisma Therapeutics, Inc. in?
Carisma Therapeutics, Inc. is in the Healthcare sector
What industry is Carisma Therapeutics, Inc. in?
Carisma Therapeutics, Inc. is in the Biotechnology industry
What country is Carisma Therapeutics, Inc. based in?
Carisma Therapeutics, Inc. is headquartered in United States
When did Carisma Therapeutics, Inc. go public?
Carisma Therapeutics, Inc. initial public offering (IPO) was on February 6, 2014
Is Carisma Therapeutics, Inc. in the S&P 500?
No, Carisma Therapeutics, Inc. is not included in the S&P 500 index
Is Carisma Therapeutics, Inc. in the NASDAQ 100?
No, Carisma Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Carisma Therapeutics, Inc. in the Dow Jones?
No, Carisma Therapeutics, Inc. is not included in the Dow Jones index
When was Carisma Therapeutics, Inc. last earnings report?
Carisma Therapeutics, Inc.'s most recent earnings report was on August 7, 2025
When does Carisma Therapeutics, Inc. report earnings?
The date for Carisma Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CARM Official Website www.carismatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1485003/000162828025020724/0001628280-25-020724-index.htm
- CARM Profile on Yahoo Finance finance.yahoo.com/quote/CARM
- CARM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/carm